GH axis evidence archiveLabels, trials, safety, regulationEducation, not treatment advice
TAIH Peptide AxisGrowth hormone axis evidence
Independent evidence library

Map the GH axis. Separate signal from outcome.

Independent reviews of approved medicines, research compounds, clinical evidence, and safety.

Browse compound filesRead evidence reviews
Scientific illustration of the growth hormone and IGF-1 signaling axis
Evidence mapGH, GHRH, IGF-1 and ghrelin receptor pathways
Evidence reviews652
Compound profiles30
Featured desks3

Every conclusion is kept inside its regulatory, population, endpoint, and safety context.

Reading key

Four claims that should never be collapsed into one.

A biomarker can move without proving a body composition benefit, a clinical outcome, or regulatory approval.

01
Hormone markersChanges in GH or IGF-1 measurements.
02
Body compositionChanges in fat or lean tissue endpoints.
03
Clinical outcomesBenefits measured in a defined disease population.
04
Approval statusA regulator has reviewed a specific indication.

Compound files, organized by regulatory reality.

Approved medicines, research peptides, secretagogues, and non-peptide comparators remain visibly distinct.

Open all compound files

Latest entries in the evidence ledger.

Regulatory changes, human studies, endocrine safety, metabolism, and sports integrity.

Continue to the evidence library

Follow the evidence question.

Topics connect mechanism, regulatory status, human data, safety, and anti-doping rules.

Product Identity

Articles organized around product identity for peptide and related research products.

0 reviewsClinical Evidence

Articles organized around clinical evidence for peptide and related research products.

0 reviewsPreclinical Research

Articles organized around preclinical research for peptide and related research products.

0 reviewsRegulatory Status

Articles organized around regulatory status for peptide and related research products.

0 reviewsSafety and Evidence Limits

Articles organized around safety and evidence limits for peptide and related research products.

0 reviewsAxis Monograph

Axis Monograph coverage produced under the pathway-first GH-axis monograph library collection rule.

218 reviewsMechanism Comparison

Mechanism Comparison coverage produced under the pathway-first GH-axis monograph library collection rule.

217 reviewsStudy Autopsy

Study Autopsy coverage produced under the pathway-first GH-axis monograph library collection rule.

217 reviews
Editorial accountability

Defined desks, visible work.

Our contributors are editorial teams with declared subject areas. We do not invent clinical credentials.

View editorial desks
EREvidence Review DeskResearch Evidence Editors0PIProduct Identity DeskCatalog Identity Editors0RCRegulatory Context DeskRegulatory Research Editors0